Single IRB workflows can reduce duplicated review, but research sites still need clear local responsibilities, reliance documentation, consent version control, and communication paths.
Written from clinical recruiting workflow patterns, buyer questions, and patient-facing product boundaries. This is educational content only; TrialsNest does not make eligibility, enrollment, treatment, or medical decisions.
How this resource is reviewed
Reviewed by TrialsNest editorial review on . Resource Hub pages are written for operational education and updated when workflow, buyer, or trust boundaries change.
What to keep in view
Questions to answer before acting on this guide
How teams usually use it
Compare it with the real queue
Read it next to the way your team already works. The gaps usually show up around ownership, missing records, follow-up timing, or sponsor-update prep.
Mark the handoffs
For each section, ask where the work changes hands. If the handoff depends on memory, a spreadsheet tab, or a buried message, that is probably worth fixing.
Keep the boundary clear
When the topic touches matching or prescreening, keep the language careful. Early fit is not enrollment, and final study decisions stay with authorized study teams.
Why this page belongs in the Resource Hub
These notes make the page purpose, audience, and next path explicit so readers can understand how this guide differs from nearby resources.
What this tool page is meant to answer
This resource is focused on single IRB clinical trials for research sites. It is designed to answer a narrow workflow question, then point readers to the adjacent TrialsNest pages that cover implementation, reporting, patient-facing trust, or product fit.
Turn the checklist into a working review
Use the questions as an operating review rather than a static download. The strongest signal is when a page helps teams decide what to check, who owns the next action, and which internal resource answers the next question.
Where to go next inside TrialsNest
Use the related topic hub and selected next reads below to move deeper into the same search intent. Those links keep this page connected to a crawlable cluster instead of leaving it as an isolated article.
Focused next reads for this topic
These links keep the page inside the same practical topic path instead of sending readers through broad navigation.
A focused resource hub for research sites organizing clinical trial recruitment operations, lead ownership, stale leads, records readiness, screening visits, and sponsor updates.
Medical-record requests can decide whether a promising patient is ready for screening, but the workflow needs clear patient explanation, secure handling, coordinator ownership, and visible review status.
Tracking patient recruitment across locations requires shared definitions and local accountability. The goal is to compare movement by site, source, blocker, owner, and next action without flattening the context each coordinator needs to work the queue.
A site-network recruitment maturity model helps leaders identify whether recruiting work is ad hoc, standardized, managed, or optimized across locations. The point is to make the next improvement obvious.
Turn this guide into a working recruitment workflow.
Walk through how patient intake, prescreening, records readiness, scheduling, and reporting connect in the product.
Single IRB readiness is operational
For many multisite studies, a single Institutional Review Board model can reduce duplicated review and create a more consistent oversight process.
NIH policy generally expects a single IRB for domestic sites in NIH-funded multisite research involving non-exempt human subjects research. For sites, the practical question is not only who the IRB is. It is whether the site is operationally ready to work under that model.
Confirm roles early
Know which IRB is reviewing the study, which institutions are relying on that review, who owns local context updates, and who handles communication between the site, sponsor, coordinating center, and IRB.
Sites should also identify which local steps remain required. Even under a single IRB, a site may still need institutional sign-off, conflict-of-interest review, ancillary committee review, training confirmation, or other local approvals.
Prepare reliance and consent workflows
Reliance documentation should be tracked before activation pressure begins. Teams need to know whether agreements, institutional approvals, and local sign-offs are complete.
Consent version control also needs attention. A site should be able to prove which consent version was approved, which version is active, and how staff are alerted when a version changes.
Use a case-study lens
A multisite study launches with central IRB approval, but one site delays activation because local ancillary review was not started. The issue is not the single IRB model itself. The issue is that local steps were invisible until the launch timeline was already compressed.
A better site activation checklist separates central IRB review from local institutional steps and assigns an owner to each dependency.
Where TrialsNest fits
TrialsNest is not an IRB system, but recruitment teams still benefit when study activation dependencies, site readiness notes, and coordinator tasks are visible in the same operating rhythm as patient follow-up.
The goal is to prevent enrollment operations from assuming a site is ready before the required review and documentation steps are complete.
Sources used for this checklist
NIH Single IRB Policy for Multi-Site Research: https://grants.nih.gov/policy-and-compliance/policy-topics/single-irb-policy-multi-site-research
HHS OHRP IRBs and Assurances: https://www.hhs.gov/ohrp/register-irbs-and-obtain-fwas/index.html
Want this workflow organized in one place?
See how TrialsNest connects patient intake, prescreening, records readiness, coordinator follow-up, scheduling, and reporting for research sites.
Related TrialsNest workflows
These resource pages connect back to the product areas buyers usually ask about: public study search, site recruitment workflow, sponsor visibility, and the privacy-aware operating model.
Use the guide to compare your current intake, follow-up, records, scheduling, and reporting steps against a connected recruitment workflow.
Review the recruitment software page to connect the operational ideas in this guide to a practical site workspace.
Topics covered
Common questions
What should teams know about single IRB clinical trials?
Single IRB workflows can reduce duplicated review, but research sites still need clear local responsibilities, reliance documentation, consent version control, and communication paths. The practical value is in connecting the concept to ownership, follow-up, records readiness, scheduling, reporting, and clear next actions.
Who is this resource written for?
This resource is written for research sites sorting through practical questions around single IRB clinical trials and the workflow decisions that usually come with it.
Does this guide replace study-team review or medical advice?
No. TrialsNest resources are educational and operational. They do not provide medical advice, diagnosis, treatment, emergency care, or final clinical trial eligibility decisions.
How would a team use this workflow guidance in practice?
Use it to compare the current workflow with what actually happens day to day: where leads wait, where records get lost, where follow-up slows down, and what needs a clearer owner. The best next step is to turn the article takeaways into a short review checklist for single IRB clinical trials.
Trust and proof points
Study-team decisions stay with authorized teams
TrialsNest can organize intake, prescreening, and workflow context, but it does not make final eligibility, enrollment, treatment, or medical decisions.
Reporting focuses on operational movement
Sponsor-ready updates should show source quality, movement, blockers, and next actions without becoming a broad patient-detail workspace.
Public pages stay educational
These resources explain clinical recruiting workflows and buying decisions. Sensitive study details belong in the appropriate secure workflow.
Continue exploring
Helpful next reads
Follow-up reading chosen from the same topic cluster and audience context as this guide.